The Effectiveness of Text Messaging for Detection and Management of Hypertension in Indigenous People in Canada: Protocol for a Randomized Controlled Trial

Karen Yeates, Norm Campbell, Marion A Maar, Nancy Perkins, Peter Liu, Jessica Sleeth, Carter Smith, Colin McAllister, Diane Hua-Stewart, George Wells, Sheldon W Tobe, Karen Yeates, Norm Campbell, Marion A Maar, Nancy Perkins, Peter Liu, Jessica Sleeth, Carter Smith, Colin McAllister, Diane Hua-Stewart, George Wells, Sheldon W Tobe

Abstract

Background: Hypertension, the leading cause of morbidity and mortality, affects more than 1 billion people and is responsible globally for 10 million deaths annually. Hypertension can be controlled on a national level; in Canada, for example, awareness, treatment, and control improved dramatically from only 16% in 1990 to 66% currently. The ongoing development, dissemination, and implementation of Hypertension Canada's clinical practice guidelines is considered to be responsible, in part, for achieving these high levels of control and the associated improvements in cardiovascular outcomes. A gap still exists between the evidence and the implementation of hypertension guidelines in Indigenous communities in Canada, as well as in low- and middle-income countries (LMICs). The rapid rise in the ownership and use of mobile phones globally and the potential for texting (short message service, SMS) to improve health literacy and to link the health team together with the patient served as a rationale for the Dream-Global study in both Canada and Tanzania.

Objective: The primary objective of the Dream-Global study is to assess the effect of innovative technologies and changes in health services delivery on blood pressure (BP) control of Indigenous people in Canada and rural Tanzanians with hypertension using SMS messages and community BP measurement through task shifting with transfer of the measures electronically to the patient and the health care team members.

Methods: This prospective, randomized blinded allocation study enrolls both adults with uncontrolled hypertension (medicated or unmedicated) and those without hypertension but at high risk of developing this condition who participate in a BP screening study. Participants will be followed for at least 12 months.

Results: The primary efficacy endpoint in this study will be assessed by analysis of variance. Descriptive data will be given with the mean and standard deviation for continuous data and proportions for ordinal data. Exploratory subgroup analyses will include analysis by community, sex, mobile phone ownership at baseline, and age. The knowledge gained from the text messages will be assessed using a questionnaire at study completion, and results will be compared between the groups.

Conclusions: This study is expected to provide insights into the implementation of an innovative system of guidelines- and community-based treatment and follow-up for hypertension in Indigenous communities in Canada and in Tanzania, an example of an LMIC. These insights are expected to provide the information needed to plan scalable and sustainable interventions to control BP virtually anywhere in the world.

Trial registration: Clinicaltrials.gov NCT02111226; https://ichgcp.net/clinical-trials-registry/NCT02111226 (Archived by WebCite at http://www.webcitation.org/6v7IdYzZh).

Keywords: chronic disease; disease management; health services, indigenous; hypertension; telemedicine; text messaging.

Conflict of interest statement

Conflicts of Interest: NC is a consultant to Novartis Foundation (regarding hypertension control in low- to middle-income cities) and to Midmark (regarding examination table design).

©Karen Yeates, Norm Campbell, Marion A Maar, Nancy Perkins, Peter Liu, Jessica Sleeth, Carter Smith, Colin McAllister, Diane Hua-Stewart, George Wells, Sheldon W Tobe. Originally published in JMIR Research Protocols (http://www.researchprotocols.org), 19.12.2017.

References

    1. Lim SS, Vos T, Flaxman AD, Danaei G, Shibuya K, Adair-Rohani H, Amann M, Anderson HR, Andrews KG, Aryee M, Atkinson C, Bacchus LJ, Bahalim AN, Balakrishnan K, Balmes J, Barker-Collo S, Baxter A, Bell ML, Blore JD, Blyth F, Bonner C, Borges G, Bourne R, Boussinesq M, Brauer M, Brooks P, Bruce NG, Brunekreef B, Bryan-Hancock C, Bucello C, Buchbinder R, Bull F, Burnett RT, Byers TE, Calabria B, Carapetis J, Carnahan E, Chafe Z, Charlson F, Chen H, Chen JS, Cheng AT, Child JC, Cohen A, Colson KE, Cowie BC, Darby S, Darling S, Davis A, Degenhardt L, Dentener F, Des Jarlais DC, Devries K, Dherani M, Ding EL, Dorsey ER, Driscoll T, Edmond K, Ali SE, Engell RE, Erwin PJ, Fahimi S, Falder G, Farzadfar F, Ferrari A, Finucane MM, Flaxman S, Fowkes FG, Freedman G, Freeman MK, Gakidou E, Ghosh S, Giovannucci E, Gmel G, Graham K, Grainger R, Grant B, Gunnell D, Gutierrez HR, Hall W, Hoek HW, Hogan A, Hosgood 3rd HD, Hoy D, Hu H, Hubbell BJ, Hutchings SJ, Ibeanusi SE, Jacklyn GL, Jasrasaria R, Jonas JB, Kan H, Kanis JA, Kassebaum N, Kawakami N, Khang YH, Khatibzadeh S, Khoo JP, Kok C, Laden F, Lalloo R, Lan Q, Lathlean T, Leasher JL, Leigh J, Li Y, Lin JK, Lipshultz SE, London S, Lozano R, Lu Y, Mak J, Malekzadeh R, Mallinger L, Marcenes W, March L, Marks R, Martin R, McGale P, McGrath J, Mehta S, Mensah GA, Merriman TR, Micha R, Michaud C, Mishra V, Mohd Hanafiah K, Mokdad AA, Morawska L, Mozaffarian D, Murphy T, Naghavi M, Neal B, Nelson PK, Nolla JM, Norman R, Olives C, Omer SB, Orchard J, Osborne R, Ostro B, Page A, Pandey KD, Parry CD, Passmore E, Patra J, Pearce N, Pelizzari PM, Petzold M, Phillips MR, Pope D, Pope 3rd CA, Powles J, Rao M, Razavi H, Rehfuess EA, Rehm JT, Ritz B, Rivara FP, Roberts T, Robinson C, Rodriguez-Portales JA, Romieu I, Room R, Rosenfeld LC, Roy A, Rushton L, Salomon JA, Sampson U, Sanchez-Riera L, Sanman E, Sapkota A, Seedat S, Shi P, Shield K, Shivakoti R, Singh GM, Sleet DA, Smith E, Smith KR, Stapelberg NJ, Steenland K, Stöckl H, Stovner LJ, Straif K, Straney L, Thurston GD, Tran JH, Van Dingenen R, van Donkelaar A, Veerman JL, Vijayakumar L, Weintraub R, Weissman MM, White RA, Whiteford H, Wiersma ST, Wilkinson JD, Williams HC, Williams W, Wilson N, Woolf AD, Yip P, Zielinski JM, Lopez AD, Murray CJ, Ezzati M, AlMazroa MA, Memish ZA. A comparative risk assessment of burden of disease and injury attributable to 67 risk factors and risk factor clusters in 21 regions, 1990-2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet. 2012 Dec 15;380(9859):2224–60. doi: 10.1016/S0140-6736(12)61766-8.
    1. Rapsomaniki E, Timmis A, George J, Pujades-Rodriguez M, Shah AD, Denaxas S, White IR, Caulfield MJ, Deanfield JE, Smeeth L, Williams B, Hingorani A, Hemingway H. Blood pressure and incidence of twelve cardiovascular diseases: lifetime risks, healthy life-years lost, and age-specific associations in 1·25 million people. Lancet. 2014 May 31;383(9932):1899–911. doi: 10.1016/S0140-6736(14)60685-1.
    1. Nagai M, Hoshide S, Kario K. Hypertension and dementia. Am J Hypertens. 2010 Feb;23(2):116–24. doi: 10.1038/ajh.2009.212.
    1. Haroun MK, Jaar BG, Hoffman SC, Comstock GW, Klag MJ, Coresh J. Risk factors for chronic kidney disease: a prospective study of 23,534 men and women in Washington County, Maryland. J Am Soc Nephrol. 2003 Nov;14(11):2934–41.
    1. Lewington S, Clarke R, Qizilbash N, Peto R, Collins R, Prospective SC. Age-specific relevance of usual blood pressure to vascular mortality: a meta-analysis of individual data for one million adults in 61 prospective studies. Lancet. 2002 Dec 14;360(9349):1903–13.
    1. Blood Pressure Lowering Treatment Trialists' Collaboration. Ninomiya T, Perkovic V, Turnbull F, Neal B, Barzi F, Cass A, Baigent C, Chalmers J, Li N, Woodward M, MacMahon S. Blood pressure lowering and major cardiovascular events in people with and without chronic kidney disease: meta-analysis of randomised controlled trials. Br Med J. 2013 Oct 03;347:f5680.
    1. Joffres MR, Ghadirian P, Fodor JG, Petrasovits A, Chockalingam A, Hamet P. Awareness, treatment, and control of hypertension in Canada. Am J Hypertens. 1997 Oct;10(10 Pt 1):1097–102.
    1. McAlister FA, Wilkins K, Joffres M, Leenen FH, Fodor G, Gee M, Tremblay MS, Walker R, Johansen H, Campbell N. Changes in the rates of awareness, treatment and control of hypertension in Canada over the past two decades. CMAJ. 2011 Jun 14;183(9):1007–13. doi: 10.1503/cmaj.101767.
    1. Campbell NR, Brant R, Johansen H, Walker RL, Wielgosz A, Onysko J, Gao RN, Sambell C, Phillips S, McAlister FA, Canadian Hypertension Education Program Outcomes Research Task Force Increases in antihypertensive prescriptions and reductions in cardiovascular events in Canada. Hypertension. 2009 Feb;53(2):128–34. doi: 10.1161/HYPERTENSIONAHA.108.119784.
    1. Kwan GF, Mayosi BM, Mocumbi AO, Miranda JJ, Ezzati M, Jain Y, Robles G, Benjamin EJ, Subramanian SV, Bukhman G. Endemic cardiovascular diseases of the poorest billion. Circulation. 2016 Jun 14;133(24):2561–75. doi: 10.1161/CIRCULATIONAHA.116.008731.
    1. Kayima J, Wanyenze RK, Katamba A, Leontsini E, Nuwaha F. Hypertension awareness, treatment and control in Africa: a systematic review. BMC Cardiovasc Disord. 2013 Aug 02;13:54. doi: 10.1186/1471-2261-13-54.
    1. Quan H, Chen X, Zhang J, Zhao PL. New paradigm for drug developments--from emerging market statistical perspective. Contemp Clin Trials. 2013 Nov;36(2):697–703. doi: 10.1016/j.cct.2013.06.009.
    1. Foulds HJ, Warburton DE. The blood pressure and hypertension experience among North American Indigenous populations. J Hypertens. 2014 Apr;32(4):724–34. doi: 10.1097/HJH.0000000000000084.
    1. Campbell N, Young ER, Drouin D, Legowski B, Adams MA, Farrell J, Kaczorowski J, Lewanczuk R, Moy Lum-Kwong M, Tobe S. A framework for discussion on how to improve prevention, management, and control of hypertension in Canada. Can J Cardiol. 2012 May;28(3):262–9. doi: 10.1016/j.cjca.2011.11.008.
    1. Tobe SW, Maar M, Roy MA, Warburton DE. Preventing cardiovascular and renal disease in Canada's aboriginal populations. Can J Cardiol. 2015 Sep;31(9):1124–9. doi: 10.1016/j.cjca.2015.05.024.
    1. King M, Smith A, Gracey M. Indigenous health part 2: the underlying causes of the health gap. Lancet. 2009 Jul 04;374(9683):76–85. doi: 10.1016/S0140-6736(09)60827-8.
    1. Anand SS, Yusuf S, Jacobs R, Davis AD, Yi Q, Gerstein H, Montague PA, Lonn E. Risk factors, atherosclerosis, and cardiovascular disease among Aboriginal people in Canada: the Study of Health Assessment and Risk Evaluation in Aboriginal Peoples (SHARE-AP) Lancet. 2001 Oct 06;358(9288):1147–53.
    1. Reading JL, Kmetic A, Gideon V. Flinders. 2007. First Nations wholistic policy and planning model. Discussion Paper for the World Health Organization Commission on Social Determinants of Health .
    1. Reading CL, Wien F. National Collaborating Centre For Aboriginal Health. 2009. [2016-12-06]. Health inequalities and the social determinants of Aboriginal peoples' health .
    1. Tobe SW, Pylypchuk G, Wentworth J, Kiss A, Szalai JP, Perkins N, Hartman S, Ironstand L, Hoppe J. Effect of nurse-directed hypertension treatment among First Nations people with existing hypertension and diabetes mellitus: the Diabetes Risk Evaluation and Microalbuminuria (DREAM 3) randomized controlled trial. CMAJ. 2006 Apr 25;174(9):1267–71. doi: 10.1503/cmaj.050030.
    1. Tobe S, Vincent L, Wentworth J, Hildebrandt D, Kiss A, Perkins N, Hartman S, Ironstand L, Hoppe J, Hunter K, Pylypchuk G. Blood pressure 2 years after a chronic disease management intervention study. Int J Circumpolar Health. 2010 Feb;69(1):50–60.
    1. Wagner EH, Groves T. Care for chronic diseases. Br Med J. 2002 Oct 26;325(7370):913–4.
    1. Thakkar J, Kurup R, Laba TL, Santo K, Thiagalingam A, Rodgers A, Woodward M, Redfern J, Chow CK. Mobile telephone text messaging for medication adherence in chronic disease: a meta-analysis. J Am Med Assoc Intern Med. 2016 Mar;176(3):340–9. doi: 10.1001/jamainternmed.2015.7667.
    1. Maar M, Yeates K, Barron M, Hua D, Liu P, Moy Lum-Kwong M, Perkins N, Sleeth J, Tobe J, Wabano MJ, Williamson P, Tobe SW. I-RREACH: an engagement and assessment tool for improving implementation readiness of researchers, organizations and communities in complex interventions. Implement Sci. 2015;10:64. doi: 10.1186/s13012-015-0257-6.
    1. Maar MA, Yeates K, Toth Z, Barron M, Boesch L, Hua-Stewart D, Liu P, Perkins N, Sleeth J, Wabano MJ, Williamson P, Tobe SW. Unpacking the black box: a formative research approach to the development of theory-driven, evidence-based, and culturally safe text messages in mobile health interventions. JMIR mHealth uHealth. 2016 Jan 22;4(1):e10. doi: 10.2196/mhealth.4994.
    1. Trickett EJ, Beehler S, Deutsch C, Green LW, Hawe P, McLeroy K, Miller RL, Rapkin BD, Schensul JJ, Schulz AJ, Trimble JE. Advancing the science of community-level interventions. Am J Public Health. 2011 Aug;101(8):1410–9. doi: 10.2105/AJPH.2010.300113.
    1. Michie S, van Stralen M, West R. The behaviour change wheel: a new method for characterising and designing behaviour change interventions. Implement Sci. 2011;6:42. doi: 10.1186/1748-5908-6-42.
    1. Whelton PK, He J, Appel LJ, Cutler JA, Havas S, Kotchen TA, Roccella EJ, Stout R, Vallbona C, Winston MC, Karimbakas J, National High Blood Pressure Education Program Coordinating Committee Primary prevention of hypertension: clinical and public health advisory from The National High Blood Pressure Education Program. J Am Med Assoc. 2002 Oct 16;288(15):1882–8.
    1. Patsopoulos NA. A pragmatic view on pragmatic trials. Dialogues Clin Neurosci. 2011;13(2):217–24.
    1. Treweek S, Zwarenstein M. Making trials matter: pragmatic and explanatory trials and the problem of applicability. Trials. 2009 Jun 03;10:37. doi: 10.1186/1745-6215-10-37.
    1. Flicker S, Worthington CA. Public health research involving aboriginal peoples: research ethics board stakeholders' reflections on ethics principles and research processes. Can J Public Health. 2012;103(1):19–22.
    1. [No authors listed] World Medical Association declaration of Helsinki. Recommendations guiding physicians in biomedical research involving human subjects. J Am Med Assoc. 1997 Mar 19;277(11):925–6.
    1. Boffa J, King M, McMullin K, Long R. A process for the inclusion of Aboriginal People in health research: lessons from the Determinants of TB Transmission project. Soc Sci Med. 2011 Mar;72(5):733–8. doi: 10.1016/j.socscimed.2010.10.033.
    1. Sedgwick P. The Hawthorne effect. Br Med J. 2012;344:d8262. doi: 10.1136/bmj.d8262. doi: 10.1136/bmj.d8262.
    1. Maar MA, Yeates K, Perkins N, Boesch L, Hua-Stewart D, Liu P, Sleeth J, Tobe SW. A framework for the study of complex mHealth interventions in diverse cultural settings. JMIR mHealth uHealth. 2017 Apr 20;5(4):e47. doi: 10.2196/mhealth.7044.

Source: PubMed

Sponsorer og samarbeidspartnere

Medisinsk tilstand

Legemiddelintervensjoner

3
Abonnere